Nomogram, Gastric Cancer
Nomograms are the prediction tools to help patients and physicians make important treatment decisions. These tools are based on the information from thousands of cancer patients and can be used to predict personalized cancer outcomes or assess risk.
The Gastric Cancer Nomogram is designed to assess prognosis after surgical treatment. The tool uses information on patient age, gender, tumor size, primary location of tumor (Antrum/pyloric, middle third, gastroesophageal junction, or proximal third), Lauren histotype based on histopathological examination (diffuse, intestinal, or mixed), and number of positive and negative lymph nodes from histopathological examination. Based on this information, the nomogram provides a percentile value of the probability of gastric cancer survival after complete tumor resection.
The gastric stromal tumor nomogram is designed for patients who have not been treated with tyrosine kinase inhibitors. The algorithm uses size of the tumor, its location (stomach, small intestine, colon, rectum), and mitotic index from histopathological examination. Based on this information, it provides the probability of recurrence-free survival after complete tumor resection.
- Useful to predict the likelihood of surviving gastric cancer for five years and nine years after complete surgical removal of all cancerous tissue
- Useful to predict likelihood of tumor recurrence following the complete resection of the gastrointestinal stromal tumor
N/A
N/A
- Lancet Oncol. 2009;10(11):1045-52. [PMID: 19793678]
- Ann Surg Oncol. 2015;22(11):3597-605. [PMID: 25652053]
- J Clin Oncol. 2003;21(19):3647-50. [PMID: 14512396]
- Memorial Sloan Kettering Cancer Center [https://www.mskcc.org/nomograms]